← All trials
NCT02579369
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 8, 2015
- Primary completion
- Apr 1, 2016
- Completion date
- Apr 30, 2023
- First posted
- Oct 19, 2015
- Last posted
- Aug 25, 2023
- Enrollment
- 2
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Anterogen Co., Ltd.Lead sponsor
- Yonsei UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.